• COVID-19
  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

by Jasmine Pennic 12/04/2020 Leave a Comment

Backed by Khosla Ventures, Rubedo Life Sciences Secures $12M for Drug Discovery Platform

What You Should Know:

– Biopharma startup Rubedo Life Sciences raises $12M to develop a broad portfolio of innovative therapies engineered to target cells for chronic age-related diseases.

– Rubedo’s proprietary ALEMBIC™ drug discovery platform, has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory and pro-fibrotic cell populations that result from a variety of cellular stress and damage.


Rubedo Life Sciences, a biopharmaceutical company committed to developing first-in-class therapies targeting senescent cells that drive age-related diseases has raised $12M in seed funding led by Khosla Ventures, with participation from Longevity Fund, Refactor Capital, Shanda, and additional investors.

Medicines Customized for Age-Related Diseases

Rubedo’s ALEMBIC™ drug discovery platform is based on a synergy between sophisticated computational and chemistry strategies. This hybrid platform enables the discovery and development of novel first-in-class engineered small molecules, such as prodrugs, designed to selectively target senescent cells, which play a key role in the progression of chronic disorders.

Senescent Cells

Rubedo’s drug discovery platform has generated a novel pipeline of therapeutic candidates that selectively target senescent cells, pro-inflammatory, and pro-fibrotic cell populations that result from a variety of cellular stress and damage. Any cells in the human body can become “senescent” over time. While in this irreversible senescence state, cells remain metabolically active but stop replicating and growing. Senescent cells release cytokines and other toxins into the bloodstream, driving chronic inflammation, which plays a key role in driving disease progression, in fibrotic diseases such as IPF, and tumor progression in cancer.

Expansion Plans

The funding will be used to advance the company’s lead candidates in respiratory diseases with a significant unmet medical needs, such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD). In addition, Rubedo will advance preclinical candidates in oncology, followed by neurodegenerative conditions, skeletal muscle disorders, and other age-related diseases. Rubedo expects to file IND application next year and initiate first-in-human clinical trials targeting senescent cells in pulmonary disorders such as idiopathic pulmonary fibrosis (IPF) and chronic obstructive pulmonary disease (COPD).

“We’re delighted to attract such a strong group of investors, led by Khosla Ventures. This significant influx of financing will allow us to advance development of our pipeline, as we move our lead products toward clinical development,” said Marco Quarta, CEO & Co-Founder of Rubedo Life Sciences.

RELATED:   30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021

Tagged With: Drug Discovery

[ultimatesocial networks="facebook,twitter,google,linkedin,mail" url="" custom_class="us-posts-bottom" align="left" count="false"]

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

« 4 Actions to Elevate the Patient Experience and Spark Growth
Innovaccer Launches COVID-19 Command Center to Help Healthcare Organizations Manage Their COVID-19 Operations »

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Recent Articles

  • Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    Hurdle Secures $5M for Digital Mental Health Platform for People of Color

    ... more
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment

    West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution

    ... more
  • Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    Onyx, AMA Innovations Form Collaboration to Build FHIR-Based Messaging

    ... more
  • op 5 business opportunities for digital health companies in 2021. Where is the money?

    Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

    ... more

Most Read

  • 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021 30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
  • Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results Intelligent Automation of the Revenue Cycle: How an Integrated Platform Approach Yields Financial Results
  • 20 COVID-19 Predictions and Trends for 2021 - Executive Roundup 20 COVID-19 Predictions and Trends for 2021 – Executive Roundup
  • 16 COVID-19 Predictions and Trends for 2021 Executive Roundup 12-Available-COVID-19-Vaccine-Management-Solutions-to-Know-In-Depth-1 22 Recently Launched COVID-19 Vaccine Management Solutions to Know
  • FDA Approves COVID-19 Oral Fluid Test for Use Nationwide In-Depth: 32 FDA-Approved COVID-19 Testing Kits
  • Job Titles for Healthcare Executives The Top 9 Most In-Demand Medical Jobs
  • Fundamental Surgery Becomes First VR Surgical Training Simulation to Gain CPD Accreditation 18 Healthcare Augmented Reality and Virtual Reality Companies to Watch
  • West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution Deployment West Virginia Launches Nation’s First Statewide COVID-19 Vaccine Distribution
  • CVS Health Launches Senior Medical Alert System, Symphony CVS Health Launches Senior Medical Alert System, Symphony
  • op 5 business opportunities for digital health companies in 2021. Where is the money? Top 5 Business Opportunities for Digital Health Companies in 2021. Where Is The Money?

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2020 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2021. HIT Consultant Media. All Rights Reserved. Privacy Policy |